GSTM1 and neoplasm: The Dutch CRC screening work group conducted a large-scale prognostic model that used Hb concentrations from two biennial FIT rounds to predict colonoscopy outcomes (advanced neoplasia) after a third round of a positive FIT (≥ 47 μg Hb/g feces) [12].